The ZERAMEX® XT Dental Implant System is intended to be surgically placed in the bone of the upper and lower jaw to provide support for prosthetic devices, such as artificial teeth, in order to restore aesthetics and chewing function. The ZERAMEX® XT Dental Implant System can be used for single or multiple unit restorations. The ZERAMEX® XT Dental Implants are indicated for delayed loading. The ZERAMEX® dental implants are specially indicated for patients with metal allergies/intolerances and chronic illnesses due to metal allergies/ intolerances.

The NobelPearl Dental Implant System is intended to be surgically placed in the bone of the upper and lower jaw to provide support for prosthetic devices, such as artificial teeth, in order to restore aesthetics and chewing function. The NobelPearl Dental Implant System can be used for single or multiple unit restorations. NobelPearl Dental Implant System are intended for delayed loading. NobelPearl Dental Implant System are specially indicated for patients with metal allergies/intolerances and chronic illness due to metal allergies/intolerances.

Device Description

The Zeramex® XT Dental Implant System is an endosseous dental implant/abutment system including various sizes of endosseous two piece dental implants, abutments, and accessories. The Zeramex® XT implants may be restored with screw retained Zeramex® XT abutments. The Zeramex® XT implants are placed using the Zeramex® XT surgical tools.

The NobelPearl Dental Implant System is an endosseous dental implant/abutment system including various sizes of endosseous two piece dental implants, abutments, and accessories. The NobelPearl Dental Implant System may be restored with screw retained NobelPearl abutments. The NobelPearl Dental Implant System are placed using the NobelPearl surgical tools.

The implants, abutments, and surgical tools for the Zeramex® XT and NobelPearl Dental Implant Systems are exactly the same; two trade names are being used for marketing purposes.

The implants, produced from aluminum toughened zirconia (conforming to ISO 6474-1:2010 Implants for Surgery - Ceramic Materials and ISO 6872:2015 Dentistry - Ceramic Materials), are provided sterile in two (2) diameters (0 4.2 mm (RB), and 5.5 mm (WB)) and three (3) lengths (8 mm, 10 mm, and 12 mm). The Ø 4.2 mm implant is also provided in 14 mm. The implants are designed with a "bolt-in tube" internal connection which provide anti-rotational features.

Straight and angular (15°) screw retained abutments, provided non-sterile in two sizes (RB; Ø 5.0 mm and SB, Ø 6.0 mm), are compatible for use with the system implants. The straight and angular abutments are made from the same zirconium materials as the system implants.

The screw retained abutments fit within four (4) retention elements and are affixed to the implant with a carbon fiber reinforced PEEK-Optima™ Ultra VICARBO® screw (straight) which fits the internal thread of the implant and provides a secure, screw retained ceramic on ceramic connection.

Healing caps and gingivaformers are also provided in the system. These components, provided in two sizes, are manufactured from PEEK and are connected to the implant using a screw. Provisional restoration components may be used to support temporary crowns after the healing period. The provisional restorations and the provisional restoration screws are made of carbon fiber reinforced PEEK.

AI/ML Overview

This document describes a 510(k) premarket notification for the Zeramex® XT Dental Implant System and NobelPearl Dental Implant System. It presents a comparison to predicate devices to demonstrate substantial equivalence, but it does not describe a study that uses acceptance criteria in the context of a diagnostic or AI device and its performance.

The document primarily focuses on demonstrating substantial equivalence for the dental implant systems based on:

Indications for Use
Materials of Construction (aluminum toughened zirconia, PEEK)
Design (two-piece, implant lengths, implant diameters, abutment angulation, screw retained implant/abutment connection, carbon-fiber reinforced PEEK screws)
Sterilization Methods
Performance data through fatigue testing and leveraging prior predicate device testing (shelf-life, packaging, transport, cleaning and sterilization validation, biocompatibility, bacterial endotoxin testing, surface composition analysis, surface roughness and contact angle testing).

Therefore, I cannot extract the requested information regarding acceptance criteria and device performance in the context of a diagnostic or AI study as it is not present in the provided text.

The closest relevant information is that fatigue testing was conducted on the subject devices against ISO 14801 standards, and "verification activities... were conducted to written protocols with predefined acceptance criteria." However, the specific acceptance criteria for the fatigue testing or the results are not explicitly detailed in a format that allows for the creation of Table 1. No information regarding test set sample size, data provenance, expert ground truth, adjudication methods, MRMC studies, standalone performance, training set details, or how ground truth was established is provided, as these are typically associated with diagnostic or AI device evaluations.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left, there is a circular seal with an eagle emblem and text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA." To the right, there is a blue square with the letters "FDA" in white. Next to the square, the text "U.S. FOOD & DRUG ADMINISTRATION" is written in blue.

November 16, 2018

Dentalpoint AG % Elizabeth Rose Manager, Medical Devices Mapi USA, Inc. 2343 Alexandria Drive Suite 100 Lexington, Kentucky 40504

Re: K180184

Trade/Device Name: Zeramex® XT Dental Implant System, NobelPearl Dental Implant System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE, NHA Dated: October 18, 2018 Received: October 19, 2018

Dear Elizabeth Rose:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm_identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Andrew I. Steen -S

for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology. General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K180184

Device Name Zeramex® XT Dental Implant System

Indications for Use (Describe)

The ZERAMEX® XT Dental Implant System is intended to be surgically placed in the bone of the upper and lower jaw to provide support for prosthetic devices, such as artificial teeth, in order to restore aesthetics and chewing function. The ZERAMEX® XT Dental Implant System can be used for single or multiple unit restorations. The ZERAMEX® XT Dental Implants are indicated for delayed loading. The ZERAMEX® XT dental implants are specially indicated for patients with metal allergies/intolerances and chronic illnesses due to metal allergies/ intolerances.

Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CER 801 Subpart D)	Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Indications for Use

510(k) Number (if known) K180184

Device Name

NobelPearl Dental Implant System

Indications for Use (Describe)

NobelPearl Dental Implant System are intended for delayed loading.

NobelPearl Dental Implant System are specially indicated for patients with metal allergies/intolerances and chronic illness due to metal allergies/intolerances.

Type of Use (Select one or both, as applicable)
☒ Prescription Use (Part 21 CFR 801 Subpart D)	☐ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

3.0 510(k) Summary

I. Submitter

Dentalpoint AG Bodenäckerstrasse 5 Spreitenbach, 8957 Switzerland

Phone: (+41) 44 542 41 71 Fax: (+41) 44 388 36 39

Contact Person: Anja Lieberherr, Quality Management Date Prepared: November 16, 2018

II. Device

Device Proprietary Name:	Zeramex® XT Dental Implant System and NobelPearl DentalImplant System
Common or Usual Name:	Dental Implant System
Classification Name:	Endosseous Dental Implant
Regulation Number:	21 CFR 872.3640
Primary Product Code:	DZE
Secondary Product Code	NHA
Device Classification	II

III. Predicate Device

Substantial equivalence is claimed to the following primary predicate devices:

Zeramex® T Dental Implant System, K133255, Dentalpoint AG
The following devices are referenced within the submission:
Zeramex® P6 Dental Implant System, K163043, Dentalpoint AG
Zeramex® P6 Dental Implant System, K152385, Dentalpoint AG

IV. Device Description

{5}------------------------------------------------

The implants, abutments, and surgical tools for the Zeramex® XT and NobelPearl Dental Implant Systems are exactly the same; two trade names are being used for marketing purposes.

V. Indications for Use

Zeramex® XT Dental Implant System

The ZERAMEX® Dental Implant System is intended to be surgically placed in the bone of the upper and lower jaw to provide support for prosthetic devices, such as artificial teeth, in order to restore aesthetics and chewing function. The ZERAMEX® Dental Implant System can be used for single or multiple unit restorations. The ZERAMEX® Dental Implants are indicated for delayed loading. The ZERAMEX® dental implants are specially indicated for patients with metal allergies/intolerances and chronic illnesses due to metal allergies/intolerances.

NobelPearl Dental Implant System

{6}------------------------------------------------

VI. Comparison of Technological Characteristics

The Zeramex® XT and NobelPearl Dental Implant Systems and the predicate devices share the following characteristics:

two-piece design (K133255 and K163043); ●
implant and abutment material of construction (K163043);
screw material of construction (K133255 and K163043);
implant lengths (K133255 and K163043);
implant diameters (K133255);
abutment angulation (K133255 and K163043);
screw retained implant/abutment connection (K163043);
provision of carbon-fiber reinforced PEEK screws (K163043); and
implant and abutment sterilization methods. ●

The Zeramex® XT and NobelPearl Dental Implant Systems are technologically different from the predicate devices with respect to the anti-rotational feature. The subject devices feature a "Bolt-In Tube" connection with four (4) retention elements, while the predicate devices have internal cylindrical connections. The Zeramex® P6 Dental Implant System also has an external hexagonal anti-rotational feature.

	Zeramex® XT and NobelPearlDental Implant Systems	Zeramex® T Dental ImplantSystem (K133255)	Zeramex® P6 Dental ImplantSystem (K163043)
Manufacturer	Dentalpoint AG	Dentalpoint AG	Dentalpoint AG
Indications forUse	The ZERAMEX® DentalImplant System is intended tobe surgically placed in the boneof the upper and lower jaw toprovide support for prostheticdevices, such as artificial teeth,in order to restore aestheticsand chewing function. TheZERAMEX® Dental ImplantSystem can be used for singleor multiple unit restorations.	The Zeramex® T DentalImplant System is intended tobe surgically placed in the boneof the upper and lower jaw toprovide support for prostheticdevices, such as artificial teeth,in order to restore chewingfunction.The Zeramex® T DentalImplant System can be used for	The Zeramex® P6 DentalImplant System is intended tobe surgically placed in the boneof the upper and lower jaw toprovide support for prostheticdevices, such as artificial teeth,in order to restore chewingfunction.The Zeramex® P6 DentalImplant System can be used for

{7}------------------------------------------------

The ZERAMEX® DentalImplants are indicated fordelayed loading. TheZERAMEX® dental implantsare specially indicated forpatients with metalallergies/intolerances andchronic illnesses due to metalallergies/intolerances.The NobelPearl Dental ImplantSystem is intended to besurgically placed in the bone ofthe upper and lower jaw toprovide support for prostheticdevices, such as artificial teeth,in order to restore aestheticsand chewing function. TheNobelPearl Dental ImplantSystem can be used for singleor multiple unit restorations.NobelPearl Dental ImplantSystem are intended for delayedloading. NobelPearl DentalImplant System are speciallyindicated for patients withmetal allergies/intolerances andchronic illness due to metalallergies/intolerances.	single or multiple unitrestorations.Zeramex® T implants areintended for delayed loading.The Zeramex® T dentalimplants are specially indicatedfor patients with metal allergiesand chronic illnesses due tometal allergies.The Zeramex® T (Ø 3.5 mm)implant may only be used in theanterior teeth in the lower jawand lateral teeth in the upperjaw.	single or multiple unitrestorations.The Zeramex® P6 implants areintended for delayed loading.The Zeramex® P6 implants arespecially indicated for patientswith metal allergies/intolerances and chronic illnessdue to metalallergies/intolerances.The Zeramex® P6 (Ø3.3mmSN) implant may only be usedin the anterior teeth in the lowerjaw and lateral incisor in theupper jaw.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------	---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------	----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Discussion

The technological difference between the subject and predicate devices does not raise new questions. As seen above, the Zeramex® XT and NobelPearl Dental Implant Systems have the same indications for use, materials of construction, design, size, surface treatment, and sterilization methods as the predicate devices. The data within this submission support that the subject devices are substantially equivalent to the identified predicate devices.

VII. Performance Data

As the subject devices are a line extension to the Zeramex® Implant Systems, verification activities, as identified through risk analysis, were conducted to written protocols with predefined acceptance criteria.

{8}------------------------------------------------

Fatigue testing in accordance with ISO 14801 Second Edition 2007-11-15 Dentistry-Implants-Dynamic Fatigue Test for Endosseous Dental Implants was conducted on the subject devices, Zeramex® XT and NobelPearl Dental Implant Systems. The fatigue testing as conducted in saline because of the ceramic/polymer device composition.

The following performance tests, conducted on the predicate devices, are being leveraged in support of this submission:

shelf-life, packaging, and transport validation studies:
cleaning and sterilization validation; ●
- o ISO 17665-1 First Edition 2006-08-15 Sterilization of Health Care Products -Moist Heat - Part 1: Requirements For The Development, Validation And Routine Control Of A Sterilization Process For Medical Devices;
- ISO/TS 17665-2:2009-01-15 Sterilization Of Health Care Products Moist Heat o - Part 2: Guidance On The Application Of ISO 17665-1;
- ISO 11737-1 Second Edition 2006-04-01 Sterilization Of Medical Devices - O Microbiological Methods - Part 1: Determination Of A Population Of Microorganisms On Products [Including: Technical Corrigendum 1 (2007)]; and
- ISO 11737-2 Second Edition 2009-11-15 Sterilization Of Medical Devices o Microbiological Methods - Part 2: Tests Of Sterility Performed In The Definition, Validation and Maintenance Of A Sterilization Process.
biocompatibility; ●
- ISO 6474-1 First Edition 2010-02-15 Implants for Surgery Ceramic Materials o Part 1: Ceramic Materials Based on High Purity Alumina, and
- o ISO 6872 Fourth Edition 2015-06-01 Dentistry Ceramic Materials.
bacterial endotoxin testing (LAL Method); ●
analysis of surface composition; and
surface roughness and contact angle testing.

Clinical Studies

Data supporting the Zeramex® T Dental Implant System and Zeramex® P6 Dental Implant System are applicable to the subject devices as the products are made from the same materials, undergo the same surface treatments, and have the same outer design. Fatigue testing supports that the subject devices can withstand clinically relevant forces.

VIII. Conclusion

Based on the above information, the Zeramex® XT and NobelPearl Implant Systems can be considered substantially equivalent to the identified predicate devices.

{9}------------------------------------------------

Although minor differences in design and technology exist between the subject and predicate devices, substantial equivalence has been demonstrated through a comparison of intended use, design, technological characteristics, and performance evaluations. Therefore, the Zeramex® XT and NobelPearl Dental Implant Systems are substantially equivalent to the predicate devices.

Regulation Number and Section

§ 872.3630 Endosseous dental implant abutment.

(a)
Identification. An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)